Search PepX: host-virus interaction
43 results
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
2JCC | AH3 RECOGNITION OF MUTANT HLA-A2 W167A | C | EFA | Immunoglobulin-like beta-sandwich |
 |
  |
2RFX | Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF | C | A | MHC antigen-recognition domain |
|
  |
2UWE | LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION | C | EFA | Immunoglobulin-like beta-sandwich |
|
  |
2V2W | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT | C | A | MHC antigen-recognition domain |
|
  |
2V2X | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. | C | A | MHC antigen-recognition domain |
|
  |
2V8W | CRYSTALLOGRAPHIC AND MASS SPECTROMETRIC CHARACTERISATION OF EIF4E WITH N7-CAP DERIVATIVES | B | A | eIF4e-like |
|
  |
2V8X | CRYSTALLOGRAPHIC AND MASS SPECTROMETRIC CHARACTERISATION OF EIF4E WITH N7-CAP DERIVATIVES | B | A | eIF4e-like |
|
  |
2V8Y | CRYSTALLOGRAPHIC AND MASS SPECTROMETRIC CHARACTERISATION OF EIF4E WITH N7-CAP DERIVATIVES | B | A | eIF4e-like |
|
  |
2VDR | INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV | C | AB |
|
|
  |
2VLJ | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | C | DEA | Immunoglobulin-like beta-sandwich |
|
  |
2VLK | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | C | DEA | Immunoglobulin-like beta-sandwich |
|
  |
2VLL | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | C | A | MHC antigen-recognition domain |
|
  |
2VLR | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | C | DEA | Immunoglobulin-like beta-sandwich |
|
  |
2VWF | GRB2 SH3C (2) | B | A |
|
|
  |
2W0Z | GRB2 SH3C (3) | B | A |
|
|
  |
2ZNE | Crystal structure of Zn2+-bound form of des3-23ALG-2 complexed with Alix ABS peptide | D | B |
|
|
  |
3BO8 | The High Resolution Crystal Structure of HLA-A1 Complexed with the MAGE-A1 Peptide | C | A |
|
|
  |
3BP4 | The high resolution crystal structure of HLA-B*2705 in complex with a Cathepsin A signal sequence peptide pCatA | C | A |
|
|
  |
3BP7 | The high resolution crystal structure of HLA-B*2709 in complex with a Cathepsin A signal sequence peptide, pCatA | C | A |
|
|
  |
3BW9 | Crystal Structure of HLA B*3508 in complex with a HCMV 12-mer peptide from the pp65 protein | C | A | MHC antigen-recognition domain |
|
  |
3BWA | Crystal Structure of HLA B*3508 in complex with a HCMV 8-mer peptide from the pp65 protein | C | A | MHC antigen-recognition domain |
|
  |
3BZF | The human non-classical major histocompatibility complex molecule HLA-E | P | A | MHC antigen-recognition domain |
|
  |
3C3O | ALIX Bro1-domain:CHMIP4A co-crystal structure | B | A |
|
|
  |
3C3Q | ALIX Bro1-domain:CHMIP4B co-crystal structure | B | A |
|
|
  |
3C3R | ALIX BRO1 CHMP4C complex | B | A |
|
|
  |
3C9N | Crystal Structure of a SARS Corona Virus Derived Peptide Bound to the Human Major Histocompatibility Complex Class I molecule HLA-B*1501 | C | A | MHC antigen-recognition domain |
|
  |
3CXW | Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I | B | A |
|
|
  |
3CY2 | Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand II | B | A |
|
|
  |
3CY3 | Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and the JNK inhibitor V | B | A |
|
|
  |
3D18 | Crystal structure of HLA-B*2709 complexed with a variant of the latent membrane protein 2 peptide (LMP2(L)) of epstein-barr virus | C | A |
|
|
  |
3DCG | Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC | F | B | POZ domain |
|
  |
3DX6 | Crystal Structure of B*4402 presenting a 10mer EBV epitope | C | A |
|
|
  |
3DX7 | Crystal Structure of HLA-B*4403 presenting 10mer EBV antigen | C | A |
|
|
  |
3DX8 | Crystal Structure of B*4405 presenting a 10mer EBV epitope | C | A |
|
|
  |
3E1R | Midbody targeting of the ESCRT machinery by a non-canonical coiled-coil in CEP55 | C | BA |
|
|
  |
3E94 | Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator fragment | B | A |
|
|
  |
3EQS | Crystal structure of human MDM2 in complex with a 12-mer peptide inhibitor | B | A |
|
|
  |
3EYF | Crystal structure of anti-human cytomegalovirus antibody 8f9 plus gB peptide | E | AB |
|
|
  |
3FUG | Crystal Structure of the Retinoid X Receptor Ligand Binding Domain Bound to the Synthetic Agonist 3-[4-Hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-phenyl]acrylic Acid | B | A |
|
|
  |
3G03 | Structure of human MDM2 in complex with high affinity peptide | B | ACD |
|
|
  |
3GIV | Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance | C | A |
|
|
  |
3GJF | Rational development of high-affinity T-cell receptor-like antibodies | C | LHA |
|
|
  |
3H0A | Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist | B | A |
|
